The daily pill called Foundayo got a fast track through the Food and Drug Administration. It will compete with the pill form ...
The Food and Drug Administration on Wednesday approved Eli Lilly's pill version of a GLP-1 medication for weight loss.
With a second oral GLP-1 for obesity now approved in the U.S., analysts have set to work parsing the blockbuster potential of ...
Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase ...
AI predicted that a forgotten breast cancer drug could be repurposed to treat many respiratory and gastrointestinal viruses, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results